The Manufacturer of the Year Award, sponsored by Wolviston Group, seeks to recognise a regional manufacturer who can clearly demonstrate outstanding performance during 2019.
Commercial success and evidence of growth, delivery of innovation and continuous improvements, environmental credentials, enhanced supplier relationships and supply chain development are all taken into account.
The winning organisation will receive £2,000 to donate to a local school of their choice to fund a STEM related project and develop vital, lasting industry‑academia links.
This year’s Manufacturer of the Year, Sterling Pharma Solutions, is a leading Contract Development Manufacturing Organisation to the Pharmaceutical Industry. The Dudley site in the North East has world class facilities and supports all stages of the drug development lifecycle.
All services are focused around the development, manufacture and supply of the key active ingredients that go into a range of drugs in therapeutic areas including oncology, anti-depressants, epilepsy, multiple sclerosis and pain. Sterling are the sole global supplier of more than 70% of the products they supply to customers, allowing them to play a pivotal role in the supply chain for a range of critical medicines.
Over the past 3 years sales have grown from £32 million to £56 million, including an 80% increase in export sales that saw them receive the Queens Award for International Trade. The local work force has increased by over 100 people also, providing valuable, highly skilled jobs in the North East. Today, Sterling UK employ over 420 people, which 30 are apprentices.
The long history and wide variety of parent companies with different cultures and heritages has enabled the Dudley site to learn and adapt to the market environment, adopting best practices to develop and mould its own unique culture. This has been the foundation of their recent success, enabling them to take advantage of favourable market trends in the innovator pharmaceutical outsourcing space.
This recent success has allowed Sterling to access growth capital that will see them invest £12 million into the Dudley site including four new milling areas housing a range of particle size reduction technologies, a solid state chemistry laboratory, four kilo manufacturing suites and expansion of the existing pilot plant capacity by 45%.readiness checks and new product introduction colleagues applied potential problem analysis to incoming and repeat manufacturing documentation. All of these were designed to identify and remove what is known as “batch killers”.
<< Back to Awards Home Page